BetterLife Pharma (BETRF) Interest & Investment Income (2012 - 2021)
BetterLife Pharma (BETRF) posted quarterly Interest & Investment Income of $12381.6 for Q1 2021, down 94.54% year-over-year from $226842.7 in Q1 2020, and up 204.51% quarter-over-quarter from -$11847.1 in Q4 2020.
BetterLife Pharma (BETRF) Interest & Investment Income (2012 - 2021) Analysis & Trends
BetterLife Pharma's Interest & Investment Income history runs 5 years deep, the most recent figure standing at $12381.6 for Q1 2021.
- In Q1 2021, Interest & Investment Income fell 94.54% year-over-year to $12381.6; the TTM figure through Jan 2021 stood at $227377.2 (up 134.08% YoY), while the FY2021 annual figure was $198.25, down 94.14% from the prior year.
- Interest & Investment Income for Q1 2021 stood at $12381.6, up from -$11847.1 in the prior quarter.
- The five-year high for Interest & Investment Income was $226842.7 in Q1 2020, with the low at -$129667.8 in Q3 2019.
- The 3-year median for Interest & Investment Income is $267.24 (2020), against an average of $24427.3.
- Peak annual rise in Interest & Investment Income reached 94.54% in 2021, while the deepest fall reached 94.54% in 2021.
- BetterLife Pharma's Interest & Investment Income stood at -$129667.8 in 2019, then jumped by 90.86% to -$11847.1 in 2020, then surged by 204.51% to $12381.6 in 2021.
- Business Quant data shows BETRF's Interest & Investment Income at $12381.6 in Q1 2021, -$11847.1 in Q4 2020, and $226842.7 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | BetterLife Pharma | 36.45 Mn | 36.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2021 | 12,381.63 |
| Oct 31, 2020 | -11,847.14 |
| Jan 31, 2020 | 226,842.67 |
| Jul 31, 2019 | -129,667.85 |
| Apr 30, 2013 | -39.00 |
| Apr 30, 2012 | -11,118.00 |